US FDA approves AbbVie's drug for Parkinson's disease - reuters.com
US FDA approves AbbVie's drug for Parkinson's disease reuters.com
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxNNXM3VVNjc3JYVmVLRGkxTXJrakVrdjlFRG80R2hQWHNZZkFqR1FVZjhldVVCalJOempscGY5OXlUa1dDTnQ0TG9zVi1ZMzJZUXVJb2VfM0ROYk9OeHNrNTJ3ejdsN2lhQ3VmZjNlU0p2ZG40VjdxMC0wZ2E3UWhPS2Ixa2sweE5uMFVrZXpmOFdEbXpGY3UwNlBxQ25Kam1HWkJPTUkteFUzSWJmWVhFelB3RzNjVUlQR004?oc=5" target="_blank">US FDA approves AbbVie's drug for Parkinson's disease</a> <font color="#6f6f6f">reuters.com</font>
Similar Stories
Related coverage based on topic and tags
US FDA approves Mirum's drug for rare bone disorder - reuters.com
US FDA approves Mirum's drug for rare bone disorder reuters.com
September 25, 2026 at 08:11 PMMerck's drug for diabetes-related eye disease meets trial goal - Reuters
Merck's drug for diabetes-related eye disease meets trial goal Reuters
September 24, 2026 at 02:52 PMUS FDA advisers endorse Grail cancer test's benefits in key vote - Reuters
US FDA advisers endorse Grail cancer test's benefits in key vote Reuters
September 23, 2026 at 11:03 PMWegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs - reuters.com
Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs reuters.com
September 21, 2026 at 05:02 AMKimberly-Clark offers remedies in bid for EU approval of Kenvue deal - reuters.com
Kimberly-Clark offers remedies in bid for EU approval of Kenvue deal reuters.com
September 23, 2026 at 04:22 PMRoche's obesity drug boosts blood sugar control, drives 15.5% weight loss in mid-stage trial - Reuters
Roche's obesity drug boosts blood sugar control, drives 15.5% weight loss in mid-stage trial Reuters
September 22, 2026 at 11:25 AM